Stockreport

How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And FDA Catalyst [Yahoo! Finance]

Insight Molecular Diagnostics Inc.  (IMDX) 
PDF The raised price target from $8 to $12 puts Insight Molecular Diagnostics more firmly on the radar for investors tracking valuation shifts. Analysts are linking this hi [Read more]